Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 108

Publication Record

Connections

Prevalence of Clinically Significant Drug-Drug Interactions Across US Children's Hospitals.
Antoon JW, Hall M, Herndon A, Carroll A, Ngo ML, Freundlich KL, Stassun JC, Frost P, Johnson DP, Chokshi SB, Brown CM, Browning WL, Feinstein JA, Grijalva CG, Williams DJ
(2020) Pediatrics 146:
MeSH Terms: Adolescent, Adult, Child, Child, Preschool, Cohort Studies, Drug Interactions, Drug Prescriptions, Drug-Related Side Effects and Adverse Reactions, Female, Hospitals, Pediatric, Humans, Infant, Male, Retrospective Studies, Risk Assessment, United States, Young Adult
Added March 29, 2022
0 Communities
1 Members
0 Resources
MeSH Terms
Crosstalk Between the Heart and Cancer: Beyond Drug Toxicity.
Moslehi J, Zhang Q, Moore KJ
(2020) Circulation 142: 684-687
MeSH Terms: American Heart Association, Drug-Related Side Effects and Adverse Reactions, Humans, Neoplasms
Added September 29, 2020
0 Communities
1 Members
0 Resources
4 MeSH Terms
Evolving insights into the mechanisms of toxicity associated with immune checkpoint inhibitor therapy.
Mangan BL, McAlister RK, Balko JM, Johnson DB, Moslehi JJ, Gibson A, Phillips EJ
(2020) Br J Clin Pharmacol 86: 1778-1789
MeSH Terms: Drug-Related Side Effects and Adverse Reactions, Humans, Immune Checkpoint Inhibitors, Incidence, Melanoma, Neoplasms, Programmed Cell Death 1 Receptor
Added September 29, 2020
0 Communities
1 Members
0 Resources
7 MeSH Terms
New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals.
Pavlos R, Deshpande P, Chopra A, Leary S, Strautins K, Nolan D, Thorborn D, Shaefer M, Rauch A, Dunn D, Montaner J, Rachlis A, Almeida CA, Choo L, James I, Redwood AJ, Li Y, Gaudieri S, Mallal SA, Phillips EJ
(2020) Hum Immunol 81: 300-304
MeSH Terms: Allergens, Aminopeptidases, Anti-HIV Agents, Dideoxynucleosides, Drug Hypersensitivity Syndrome, Drug-Related Side Effects and Adverse Reactions, Female, Genetic Association Studies, Genetic Predisposition to Disease, Genotype, HIV Infections, HIV-1, HLA-B Antigens, Humans, Lipopolysaccharide Receptors, Male, Minor Histocompatibility Antigens, Phenotype, Retrospective Studies
Added March 30, 2020
0 Communities
1 Members
0 Resources
19 MeSH Terms
Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use.
Jerome RN, Joly MM, Kennedy N, Shirey-Rice JK, Roden DM, Bernard GR, Holroyd KJ, Denny JC, Pulley JM
(2020) Drug Saf 43: 567-582
MeSH Terms: Drug Approval, Drug-Related Side Effects and Adverse Reactions, Electronic Health Records, Genome-Wide Association Study, Humans, Phenotype, Whites
Added March 24, 2020
0 Communities
1 Members
0 Resources
7 MeSH Terms
Single-cell transcriptomics reveal polyclonal memory T-cell responses in skin with positive abacavir patch test results.
Redwood AJ, Rwandamuriye F, Chopra A, Leary S, Ram R, McDonnell W, Konvinse K, White K, Pavlos R, Koelle DM, Mallal S, Phillips EJ
(2019) J Allergy Clin Immunol 144: 1413-1416.e7
MeSH Terms: Aged, Anti-HIV Agents, Arthralgia, CD8-Positive T-Lymphocytes, Dideoxynucleosides, Drug Hypersensitivity, Drug-Related Side Effects and Adverse Reactions, Gene Expression Profiling, HLA-B Antigens, Headache, Humans, Immunologic Memory, Lymphocyte Activation, Male, Myalgia, Patch Tests, Single-Cell Analysis, Skin
Added March 30, 2020
0 Communities
1 Members
0 Resources
18 MeSH Terms
Pharmacogenomics.
Roden DM, McLeod HL, Relling MV, Williams MS, Mensah GA, Peterson JF, Van Driest SL
(2019) Lancet 394: 521-532
MeSH Terms: Clinical Trials as Topic, Drug-Related Side Effects and Adverse Reactions, Humans, Pharmacogenetics, Pharmacogenomic Variants
Added March 24, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study.
Johnson DB, Manouchehri A, Haugh AM, Quach HT, Balko JM, Lebrun-Vignes B, Mammen A, Moslehi JJ, Salem JE
(2019) J Immunother Cancer 7: 134
MeSH Terms: Drug-Related Side Effects and Adverse Reactions, Female, Humans, Immunotherapy, Male, Nervous System Diseases, Pharmacovigilance, Retrospective Studies
Added November 12, 2019
0 Communities
1 Members
0 Resources
8 MeSH Terms
Adverse events 2.0-Let us get SERIOs: New reporting forĀ adverse event outcomes needed in the era of immunooncology.
Heinzerling L, Ascierto PA, Dummer R, Gogas H, Grob JJ, Lebbe C, Long GV, McArthur G, Moslehi JJ, Neilan TG, Ribas A, Robert C, Schadendorf D, Wolchok JD, Hauschild A
(2019) Eur J Cancer 112: 29-31
MeSH Terms: Adverse Drug Reaction Reporting Systems, Antineoplastic Agents, Autoimmune Diseases, Drug-Related Side Effects and Adverse Reactions, Humans, Immunotherapy, Neoplasms
Added November 12, 2019
0 Communities
1 Members
0 Resources
7 MeSH Terms
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer.
Dieci MV, Conte P, Bisagni G, Brandes AA, Frassoldati A, Cavanna L, Musolino A, Giotta F, Rimanti A, Garrone O, Bertone E, Cagossi K, Sarti S, Ferro A, Piacentini F, Maiorana A, Orvieto E, Sanders M, Miglietta F, Balduzzi S, D'Amico R, Guarneri V
(2019) Ann Oncol 30: 418-423
MeSH Terms: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Chemotherapy, Adjuvant, Disease-Free Survival, Drug-Related Side Effects and Adverse Reactions, Female, Humans, Kaplan-Meier Estimate, Lymphocytes, Tumor-Infiltrating, Middle Aged, Neoplasm Recurrence, Local, Receptor, ErbB-2, Trastuzumab, Treatment Outcome
Added April 2, 2019
0 Communities
1 Members
0 Resources
16 MeSH Terms